Of course, we also noted that the percentage of bleeding events intersecting with thrombocytopenia was less than 10% for each of the other six HER2 inhibitors, which may prove that thrombocytopenia is not strongly correlated with bleeding events in users of these drugs. The gene discussed is ERBB2; the disease is Thrombocytopenia.